These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19155886)

  • 21. [Similarity of Clinically Significant Neuropsychiatric Adverse Reactions Listed in Package Inserts between the Anti-influenza Drugs Oseltamivir and Amantadine (Possibility Attributable to Common Pharmacological Effects)].
    Ono H; Okamura M; Fukushima A
    Yakugaku Zasshi; 2018 Sep; 138(9):1201-1215. PubMed ID: 29925727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiviral drugs for seasonal influenza 2014-2015.
    Med Lett Drugs Ther; 2014; 56(1457):121-3. PubMed ID: 25423066
    [No Abstract]   [Full Text] [Related]  

  • 23. A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B.
    Kawai N; Ikematsu H; Iwaki N; Maeda T; Kanazawa H; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Nagai T; Horii S; Hirotsu N; Kashiwagi S
    J Infect; 2008 Jan; 56(1):51-7. PubMed ID: 17936910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropsychiatric adverse events and oseltamivir for prophylaxis.
    Jones M; Hama R; Jefferson T; Doshi P
    Drug Saf; 2012 Dec; 35(12):1187-8; author reply 1188-90. PubMed ID: 23137156
    [No Abstract]   [Full Text] [Related]  

  • 25. The safety of oseltamivir in patients with influenza: analysis of healthcare claims data from six influenza seasons.
    Blumentals WA; Song X
    MedGenMed; 2007 Oct; 9(4):23. PubMed ID: 18311373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Can oseltamivir (Tamiflu) be used in dialysis-requiring renal failure?].
    Rosenborg S
    Lakartidningen; 2010 Jan 20-26; 107(3):116-7. PubMed ID: 20225688
    [No Abstract]   [Full Text] [Related]  

  • 27. [Countermeasures for newly-emerging influenza].
    Sugaya N
    Nihon Naika Gakkai Zasshi; 2007 Nov; 96(11):2393-9. PubMed ID: 18069288
    [No Abstract]   [Full Text] [Related]  

  • 28. Zanamivir treatment is equally effective for both influenza A and influenza B.
    Kawai N; Ikematsu H; Iwaki N; Tanaka O; Yamanishi Y; Hirotsu N; Kashiwagi S
    Clin Infect Dis; 2007 Jun; 44(12):1666. PubMed ID: 17516418
    [No Abstract]   [Full Text] [Related]  

  • 29. Post-marketing assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: an updated review.
    Toovey S; Prinssen EP; Rayner CR; Thakrar BT; Dutkowski R; Koerner A; Chu T; Sirzen-Zelenskaya A; Britschgi M; Bansod S; Donner B
    Adv Ther; 2012 Oct; 29(10):826-48. PubMed ID: 23054689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zanamivir: new indication. Influenza: in children as in adults, symptom relief or vaccination.
    Prescrire Int; 2008 Aug; 17(96):141. PubMed ID: 19480096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks.
    Anekthananon T; Pukrittayakamee S; Ratanasuwan W; Jittamala P; Werarak P; Charunwatthana P; Suwanagool S; Lawpoolsri S; Stepniewska K; Sapchookul P; Puthavathana P; Fukuda C; Lindegardh N; Tarning J; White NJ; Day N; Taylor WR
    J Antimicrob Chemother; 2013 Mar; 68(3):697-707. PubMed ID: 23143901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adolescent jump case in Japan associated with influenza but not oseltamivir.
    Terada K; Kawai Y; Monju A; Wakabayashi T; Ouchi K
    Pediatr Infect Dis J; 2008 Jan; 27(1):88-9. PubMed ID: 18162953
    [No Abstract]   [Full Text] [Related]  

  • 33. Anti-viral drugs in flu: not that good?
    Arch Dis Child; 2014 Aug; 99(8):766. PubMed ID: 24914094
    [No Abstract]   [Full Text] [Related]  

  • 34. [Zanamivir for prevention of influenza and in children].
    Martini B
    Med Monatsschr Pharm; 2007 Mar; 30(3):113-4. PubMed ID: 17405488
    [No Abstract]   [Full Text] [Related]  

  • 35. Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010.
    Greene SK; Li L; Shay DK; Fry AM; Lee GM; Jacobsen SJ; Baxter R; Irving SA; Jackson ML; Naleway AL; Nordin JD; Narwaney KJ; Lieu TA
    Pharmacoepidemiol Drug Saf; 2013 Apr; 22(4):335-44. PubMed ID: 23129321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influenza: a recurrent challenge to transplantation.
    Ison MG; Hirsch HH
    Transpl Infect Dis; 2010 Apr; 12(2):95-7. PubMed ID: 20487416
    [No Abstract]   [Full Text] [Related]  

  • 37. H1N1 influenza in pregnancy: cause for concern.
    Spradlin TL; Clardy BH; Payne EM; Vinson J
    Obstet Gynecol; 2010 Jan; 115(1):185. PubMed ID: 20027058
    [No Abstract]   [Full Text] [Related]  

  • 38. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(35):969-72. PubMed ID: 19745803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethical considerations regarding the administration of oseltamivir for infection control indications.
    Collins C; Drew R; Cormican M
    Clin Infect Dis; 2007 Jul; 45(1):133-4; author reply 134-5. PubMed ID: 17554715
    [No Abstract]   [Full Text] [Related]  

  • 40. Oseltamivir: cardiac and visual disorders: add-on toxicity.
    Prescrire Int; 2009 Aug; 18(102):167. PubMed ID: 19743581
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.